- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Kodak continues executive changes
Eastman Kodak continues to revamp its executive lineup. The Rochester,NY, film and PACS vendor announced several new personnel movesas part of the ongoing restructuring of its Health Sciences division(SCAN 10/11/95). Kodak has hired Camtronics veteran
Eastman Kodak continues to revamp its executive lineup. The Rochester,NY, film and PACS vendor announced several new personnel movesas part of the ongoing restructuring of its Health Sciences division(SCAN 10/11/95).
Kodak has hired Camtronics veteran Terence Rourke as directorof digital products marketing for cardiology. Kodak's cardiologyproducts unit manufactures cine films, processing chemicals andaccessories for the cardiac cath lab market.
Anne Robson has been named executive director of Kodak's healthcarebusiness and imaging group. Robson, who was previously the group'smarketing director, will manage all aspects of the unit, whichadvises health-care facilities on achieving operational efficiencies.She succeeds Richard Cimino, who is now general manager and vicepresident of the U.S. northeast region for Health Sciences.
New AI-Powered Ultrasound Devices May Enhance Efficiency in Women's Imaging
April 19th 2024One of the features on the new Voluson Signature 20 and 18 ultrasound devices reportedly uses automated AI tools to facilitate a 40 percent reduction in the time it takes to perform second trimester exams.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
